Schubert & CO Xencor Inc Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$25.95 - $36.95 $51 - $73	-2 Reduced 11.11%	16 $0
Q4 2022 Jan 31, 2023	BUY	$24.79 - $30.86 $99 - $123	4 Added 28.57%	18 $0
Q3 2022 Oct 21, 2022	BUY	$24.62 - $32.44 $123 - $162	5 Added 55.56%	14 $0
Q2 2022 Aug 01, 2022	BUY	$19.74 - $29.01 $138 - $203	7 Added 350.0%	9 $0
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $53 - $83	2 New	2 $0

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.43B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.